A. Comparaison-entre-les-groupes-quétiapine, 106 3.2.1. Caractéristiques sociodémographiques, p.106

E. Vieta and J. Sanchez-moreno, Acute and long-term treatment of mania, Dialogues Clin Neurosci, vol.10, issue.2, pp.165-79, 2008.

A. Muneer, Pharmacotherapy of Bipolar Disorder with Quetiapine: A Recent Literature Review and an Update, Clinical Psychopharmacology and Neuroscience, vol.13, issue.1, pp.25-35, 2015.
DOI : 10.9758/cpn.2015.13.1.25

J. Delay and P. Deniker, Psycho-pharmacologie et médicaments psychiatriques, Acquis Médicales Récent, pp.195-207, 1957.

M. Jibson and R. Tandon, New atypical antipsychotic medications, Journal of Psychiatric Research, vol.32, issue.3-4, pp.3-4215, 1998.
DOI : 10.1016/S0022-3956(98)00023-5

J. Kane, G. Honigfeld, J. Singer, and H. Meltzer, Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine. Arch Gen Psychiatry, pp.789-96, 1988.

A. Maher and G. Theodore, Summary of the comparative effectiveness review on offlabel use of atypical antipsychotics, J Manag Care Pharm JMCP. 2012, vol.18, issue.5, pp.1-20

. American-psychiatric-association, Practice guideline for the treatment of patients with bipolar disorder (revision), Am J Psychiatry, vol.159, issue.4, pp.1-50, 2002.

M. A. Robert and M. D. Hirschfeld, American Psychiatric Association Guideline Watch: Practice guideline for the treatment of patients with bipolar disorder, Am J Psychiatry, 2005.

H. Grunze, E. Vieta, G. Goodwin, C. Bowden, R. Licht et al., The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2012 on the long-term treatment of bipolar disorder, The World Journal of Biological Psychiatry, vol.16, issue.9, 2013.
DOI : 10.1192/bjp.133.5.429

L. Yatham, S. Kennedy, S. Parikh, A. Schaffer, S. Beaulieu et al., Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013, Bipolar Disorders, vol.131, issue.Suppl. 1, 2013.
DOI : 10.1111/bdi.12025

G. Goodwin, Evidence-based guidelines for treating bipolar disorder: revised second edition--recommendations from the British Association for Psychopharmacology, Journal of Psychopharmacology, vol.23, issue.4, pp.346-88, 2009.
DOI : 10.1177/0269881109102919

G. Malhi, D. Adams, L. Lampe, M. Paton, O. Connor et al., Clinical practice recommendations for bipolar disorder, Acta Psychiatrica Scandinavica, vol.2, issue.s434, pp.27-46, 2009.
DOI : 10.1111/j.1600-0447.2009.01383.x

H. Grunze, E. Vieta, G. Goodwin, C. Bowden, R. Licht et al., The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2010 on the treatment of acute bipolar depression, World J Biol Psychiatry Off J World Fed Soc Biol Psychiatry, 2010.

M. Bauer, A. Pfennig, E. Severus, P. Whybrow, J. Angst et al., World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 1: Update 2013 on the acute and continuation treatment of unipolar depressive disorders, The World Journal of Biological Psychiatry, vol.34, issue.3, pp.334-85, 2013.
DOI : 10.1126/science.1121613

M. Bauer, E. Severus, S. Köhler, P. Whybrow, J. Angst et al., World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders. Part 2: Maintenance Treatment of Major Depressive Disorder-Update 2015, The World Journal of Biological Psychiatry, vol.182, issue.2, pp.76-95, 2015.
DOI : 10.1016/j.jad.2009.06.044

A. Ravindran, A. Al-subaie, and G. Abraham, Quetiapine: novel uses in the treatment of depressive and anxiety disorders, Expert Opinion on Investigational Drugs, vol.12, issue.35, pp.1187-204, 2010.
DOI : 10.4088/JCP.09m05284yel

M. Stahl-stephen, Psychopharmacologie essentielle (4° Éd.) : Bases neuroscientifiques et applications pratiques, LAVOISIER, 2016.

N. Franck and F. Thibaut, Pharmacologie et mode d'action des neuroleptiques, EMC, pp.37-860, 2005.

Z. Wang, D. Kemp, P. Chan, Y. Fang, S. Ganocy et al., Comparisons of the tolerability and sensitivity of quetiapine-XR in the acute treatment of schizophrenia, bipolar mania, bipolar depression, major depressive disorder, and generalized anxiety disorder, The International Journal of Neuropsychopharmacology, vol.14, issue.01, pp.131-173, 2011.
DOI : 10.1017/S146114571000101X

C. Bowden, H. Grunze, J. Mullen, M. Brecher, B. Paulsson et al., A Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Quetiapine or Lithium as Monotherapy for Mania in Bipolar Disorder, The Journal of Clinical Psychiatry, vol.66, issue.01, 2005.
DOI : 10.4088/JCP.v66n0116

J. Calabrese, P. Keck, W. Macfadden, M. Minkwitz, T. Ketter et al., A Randomized, Double-Blind, Placebo-Controlled Trial of Quetiapine in the Treatment of Bipolar I or II Depression, American Journal of Psychiatry, vol.162, issue.7, pp.1351-60, 2005.
DOI : 10.1176/appi.ajp.162.7.1351

T. Ketter, S. Miller, B. Dell-'osso, and P. Wang, Treatment of bipolar disorder: Review of evidence regarding quetiapine and lithium, Journal of Affective Disorders, vol.191, pp.256-73, 2016.
DOI : 10.1016/j.jad.2015.11.002

R. Weisler, W. Nolen, A. Neijber, A. Hellqvist, and B. Paulsson, Trial 144 Study Investigators. Continuation of quetiapine versus switching to placebo or lithium for maintenance treatment of bipolar I disorder, Trial, vol.144

D. Bond, M. Kauer-sant-'anna, R. Lam, and L. Yatham, Weight gain, obesity, and metabolic indices following a first manic episode: Prospective 12-month data from the Systematic Treatment Optimization Program for Early Mania (STOP-EM), Journal of Affective Disorders, vol.124, issue.1-2, pp.108-125, 2010.
DOI : 10.1016/j.jad.2009.10.023

R. Keefe, S. Silva, D. Perkins, and J. Lieberman, The Effects of Atypical Antipsychotic Drugs on Neurocognitive Impairment in Schizophrenia: A Review and Meta-analysis, Schizophrenia Bulletin, vol.25, issue.2
DOI : 10.1093/oxfordjournals.schbul.a033374

R. Daglas, S. Cotton, K. Allott, M. Yücel, C. Macneil et al., A single-blind, randomised controlled trial on the effects of lithium and quetiapine monotherapy on the trajectory of cognitive functioning in first episode mania: A 12-month follow-up study, European Psychiatry, vol.31, pp.201620-201628
DOI : 10.1016/j.eurpsy.2015.09.460

C. Torrent, A. Martinez-arán, C. Daban, B. Amann, V. Balanzá-martínez et al., Effects of atypical antipsychotics on neurocognition in euthymic bipolar patients. Compr Psychiatry, pp.613-635, 2011.
URL : https://hal.archives-ouvertes.fr/inserm-00663897

H. Verdoux, Les médicaments psychotropes : les thymorégulateurs. Lavoisier, 2013.

S. Leucht, A. Cipriani, L. Spineli, D. Mavridis, D. Orey et al., Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis, The Lancet, vol.382, issue.9896, pp.951-62, 2013.
DOI : 10.1016/S0140-6736(13)60733-3

P. Llorca, P. Courtet, P. Martin, M. Abbar, C. Gay et al., Screening and management of bipolar disorders: results]. L'Encéphale, pp.86-102, 2010.

H. Li, C. Ma, G. Wang, X. Zhu, M. Peng et al., Response and remission rates in Chinese patients with bipolar mania treated for 4 weeks with either quetiapine or lithium: a randomized and double-blind study, Current Medical Research and Opinion, vol.24, issue.1, pp.1-10, 2008.
DOI : 10.1185/030079908X253933

M. Delbello, R. Kowatch, C. Adler, K. Stanford, J. Welge et al., A double-blind randomized pilot study comparing quetiapine and divalproex for adolescent mania. J Am Acad Child Adolesc Psychiatry, pp.305-318, 2006.

D. Feifel, B. Galangue, K. Macdonald, P. Cobb, A. Dinca et al., Single-blind Comparison of Rapid Dose Administration of Divalproex ER Versus Quetiapine in Patients with Acute Bipolar Mania, Innov Clin Neurosci, vol.8, issue.1, p.29, 2011.

R. Mcintyre, M. Brecher, B. Paulsson, K. Huizar, and J. Mullen, Quetiapine or haloperidol as monotherapy for bipolar mania???a 12-week, double-blind, randomised, parallel-group, placebo-controlled trial, European Neuropsychopharmacology, vol.15, issue.5, pp.573-85, 2005.
DOI : 10.1016/j.euroneuro.2005.02.006

A. Cutler, C. Datto, A. Nordenhem, M. Minkwitz, L. Acevedo et al., Extended-Release Quetiapine as Monotherapy for the Treatment of Adults With Acute Mania: A Randomized, Double-Blind, 3-Week Trial, Clinical Therapeutics, vol.33, issue.11, pp.1643-58, 2011.
DOI : 10.1016/j.clinthera.2011.10.002

S. Pathak, R. Findling, W. Earley, L. Acevedo, J. Stankowski et al., Efficacy and Safety of Quetiapine in Children and Adolescents With Mania Associated With Bipolar I Disorder, The Journal of Clinical Psychiatry, vol.74, issue.01, 2013.
DOI : 10.4088/JCP.11m07424

E. Vieta, J. Mullen, M. Brecher, B. Paulsson, and M. Jones, Quetiapine monotherapy for mania associated with bipolar disorder: combined analysis of two international, double-blind, randomised, placebo-controlled studies, Current Medical Research and Opinion, vol.21, issue.6, pp.923-957, 2005.
DOI : 10.1185/030079905X46340

A. Cipriani, C. Barbui, G. Salanti, J. Rendell, R. Brown et al., Comparative efficacy and acceptability of antimanic drugs in acute mania: a multiple-treatments meta-analysis, The Lancet, vol.378, issue.9799, pp.1306-1321, 2011.
DOI : 10.1016/S0140-6736(11)60873-8

A. Yildiz, E. Vieta, S. Leucht, and R. Baldessarini, Efficacy of antimanic treatments: metaanalysis of randomized, controlled trials. Neuropsychopharmacol Off Publ Am Coll Neuropsychopharmacol, pp.375-89, 2011.

M. Delbello, M. Schwiers, H. Rosenberg, and S. Strakowski, A double-blind, randomized, placebo-controlled study of quetiapine as adjunctive treatment for adolescent mania. J Am Acad Child Adolesc Psychiatry, pp.1216-1239, 2002.

L. Yatham, E. Vieta, A. Young, H. Möller, B. Paulsson et al., A double blind, randomized, placebo-controlled trial of quetiapine as an add-on therapy to lithium or divalproex for the treatment of bipolar mania, International Clinical Psychopharmacology, vol.22, issue.4, 2007.
DOI : 10.1097/YIC.0b013e328080ca57

M. Bourin, E. Severus, J. Schronen, P. Gass, J. Szamosi et al., Lithium as add-on to quetiapine XR in adult patients with acute mania: a 6-week, multicenter, double-blind, randomized, placebo-controlled study, International Journal of Bipolar Disorders, vol.133, issue.3, p.14, 2014.
DOI : 10.1186/s40345-014-0014-9

C. Pae, N. Ghaemi, S. Kim, T. Kim, J. Lee et al., Rapid titration versus conventional titration of quetiapine in the treatment of bipolar mania: a preliminary trial, International Clinical Psychopharmacology, vol.20, issue.6, pp.327-357, 2005.
DOI : 10.1097/00004850-200511000-00008

T. Suppes, T. Ketter, I. Gwizdowski, E. Dennehy, S. Hill et al., First controlled treatment trial of bipolar II hypomania with mixed symptoms: Quetiapine versus placebo, Journal of Affective Disorders, vol.150, issue.1, pp.37-43, 2013.
DOI : 10.1016/j.jad.2013.02.031

L. Smith, V. Cornelius, A. Warnock, M. Tacchi, and D. Taylor, Acute bipolar mania: a systematic review and meta-analysis of co-therapy vs. monotherapy, Acta Psychiatrica Scandinavica, vol.31, issue.3, pp.12-20, 2007.
DOI : 10.1097/00004714-200004000-00012

T. Ketter, Monotherapy versus combined treatment with second-generation antipsychotics in bipolar disorder, J Clin Psychiatry, vol.69, pp.9-15, 2008.

L. Judd, H. Akiskal, P. Schettler, J. Endicott, J. Maser et al., The Long-term Natural History of the Weekly Symptomatic Status of Bipolar I Disorder, Archives of General Psychiatry, vol.59, issue.6, pp.530-537, 2002.
DOI : 10.1001/archpsyc.59.6.530

R. Baldessarini, E. Vieta, J. Calabrese, M. Tohen, and C. Bowden, Bipolar Depression: Overview and Commentary, Harvard Review of Psychiatry, vol.18, issue.3, pp.143-57, 2010.
DOI : 10.3109/10673221003747955

R. Weisler, J. Calabrese, M. Thase, R. Arvekvist, G. Stening et al., Efficacy of Quetiapine Monotherapy for the Treatment of Depressive Episodes in Bipolar I Disorder, The Journal of Clinical Psychiatry, vol.69, issue.5, pp.769-82, 2008.
DOI : 10.4088/JCP.v69n0510

M. Tohen, E. Vieta, J. Calabrese, T. Ketter, G. Sachs et al., Efficacy of Olanzapine and Olanzapine-Fluoxetine Combination in the Treatment of Bipolar I Depression, Archives of General Psychiatry, vol.60, issue.11, pp.1079-88, 2003.
DOI : 10.1001/archpsyc.60.11.1079

T. Suppes, C. Datto, M. Minkwitz, A. Nordenhem, C. Walker et al., Effectiveness of the extended release formulation of quetiapine as monotherapy for the treatment of acute bipolar depression, Journal of Affective Disorders, vol.121, issue.1-2, pp.1-2106, 2010.
DOI : 10.1016/j.jad.2009.10.007

A. Young, S. Mcelroy, M. Bauer, N. Philips, W. Chang et al., A doubleblind , placebo-controlled study of quetiapine and lithium monotherapy in adults in the acute phase of bipolar depression (EMBOLDEN I), J Clin Psychiatry, 2010.

S. Mcelroy, R. Weisler, W. Chang, B. Olausson, B. Paulsson et al., A Double-Blind, Placebo-Controlled Study of Quetiapine and Paroxetine as Monotherapy in Adults With Bipolar Depression (EMBOLDEN II), The Journal of Clinical Psychiatry, vol.71, issue.02, pp.163-74, 2010.
DOI : 10.4088/JCP.08m04942gre

S. Kim, Y. Lee, Y. Lee, and S. Cho, Effect of quetiapine XR on depressive symptoms and sleep quality compared with lithium in patients with bipolar depression, Journal of Affective Disorders, vol.157, pp.33-40
DOI : 10.1016/j.jad.2013.12.032

V. Selle, S. Schalkwijk, G. Vázquez, and R. Baldessarini, Treatments for Acute Bipolar Depression: Meta-analyses of Placebo-controlled, Monotherapy Trials of Anticonvulsants, Lithium and Antipsychotics, Pharmacopsychiatry, vol.47, issue.02, pp.43-52, 2014.
DOI : 10.1055/s-0033-1363258

Y. Ahn, J. Nam, J. Culver, W. Marsh, J. Bonner et al., Lamotrigine plus quetiapine combination therapy in treatment-resistant bipolar depression, Ann Clin Psychiatry Off J Am Acad Clin Psychiatr. Feb, vol.23, issue.1, pp.17-24, 2011.

J. Geddes, A. Gardiner, J. Rendell, M. Voysey, E. Tunbridge et al., Comparative evaluation of quetiapine plus lamotrigine combination versus quetiapine monotherapy (and folic acid versus placebo) in bipolar depression

. Factorial and . Trial, Lancet Psychiatry, pp.31-40, 2016.

S. Suttajit, M. Srisurapanont, N. Maneeton, and B. Maneeton, Quetiapine for acute bipolar depression: a systematic review and meta-analysis, Drug Design, Development and Therapy, vol.8, pp.827-865, 2014.
DOI : 10.2147/DDDT.S63779

A. Altamura, D. Salvadori, D. Madaro, A. Santini, and E. Mundo, Efficacy and tolerability of quetiapine in the treatment of bipolar disorder: preliminary evidence from a 12-month open-label study, Journal of Affective Disorders, vol.76, issue.1-3, pp.1-3267, 2003.
DOI : 10.1016/S0165-0327(02)00075-7

A. Nierenberg, L. Sylvia, A. Leon, N. Reilly-harrington, L. Shesler et al., Clinical and Health Outcomes Initiative in Comparative Effectiveness for Bipolar Disorder (Bipolar CHOICE): A pragmatic trial of complex treatment for a complex disorder, Clinical Trials, vol.64, issue.1, pp.114-141, 2014.
DOI : 10.1056/NEJMoa0806994

J. Hayes, L. Marston, K. Walters, J. Geddes, M. King et al., Lithium vs. valproate vs. olanzapine vs. quetiapine as maintenance monotherapy for bipolar disorder: a population-based UK cohort study using electronic health records, World Psychiatry, vol.386, issue.1, pp.53-61, 2016.
DOI : 10.1002/wps.20298

K. Sokolski and T. Denson, Adjunctive quetiapine in bipolar patients partially responsive to lithium or valproate, Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol.27, issue.5, 2003.
DOI : 10.1016/S0278-5846(03)00145-3

T. Suppes, D. Kelly, P. Keck, S. Mcelroy, L. Altshuler et al., Quetiapine for the continuation treatment of bipolar depression: naturalistic prospective case series from the Stanley Bipolar Treatment Network, International Clinical Psychopharmacology, vol.22, issue.6, 2007.
DOI : 10.1097/YIC.0b013e3281c55f63

M. Hardoy, A. Garofalo, B. Carpiniello, J. Calabrese, and M. Carta, Combination quetiapine therapy in the long-term treatment of patients with bipolar I disorder, Clinical Practice and Epidemiology in Mental Health, vol.1, issue.1, p.7, 2005.
DOI : 10.1186/1745-0179-1-7

A. Altamura, E. Mundo, B. Dell-'osso, G. Tacchini, M. Buoli et al., Quetiapine and classical mood stabilizers in the long-term treatment of Bipolar Disorder: A 4-year follow-up naturalistic study, Journal of Affective Disorders, vol.110, issue.1-2, pp.135-176, 2008.
DOI : 10.1016/j.jad.2008.01.017

P. Ittasakul, K. Johnson, S. Srivastava, M. Childers, J. Brooks et al., Effectiveness of quetiapine plus lamotrigine maintenance therapy in challenging bipolar disorder patients, Journal of Affective Disorders, vol.137, issue.1-3, pp.1-3139, 2012.
DOI : 10.1016/j.jad.2011.12.024

E. Vieta, T. Suppes, I. Eggens, I. Persson, B. Paulsson et al., Efficacy and safety of quetiapine in combination with lithium or divalproex for maintenance of patients with bipolar I disorder (international trial 126), Journal of Affective Disorders, vol.109, issue.3, pp.251-63, 2008.
DOI : 10.1016/j.jad.2008.06.001

T. Suppes, E. Vieta, S. Liu, M. Brecher, and B. Paulsson, Maintenance Treatment for Patients With Bipolar I Disorder: Results From a North American Study of Quetiapine in Combination With Lithium or Divalproex (Trial 127), Trial 127 Investigators, pp.476-88, 2009.
DOI : 10.1176/appi.ajp.2008.08020189

T. Suppes, E. Vieta, U. Gustafsson, and B. Ekholm, Maintenance treatment with quetiapine when combined with either lithium or divalproex in bipolar I disorder: analysis of two large randomized, placebo-controlled trials. Depress Anxiety, 2013.

E. Vieta, T. Suppes, B. Ekholm, M. Udd, and U. Gustafsson, Long-term efficacy of quetiapine in combination with lithium or divalproex on mixed symptoms in bipolar I disorder, J Affect Disord, vol.142, pp.1-336, 2012.

E. Vieta, O. Günther, J. Locklear, M. Ekman, C. Miltenburger et al., Effectiveness of psychotropic medications in the maintenance phase of bipolar disorder: a meta-analysis of randomized controlled trials, The International Journal of Neuropsychopharmacology, vol.14, issue.08, pp.1029-1078, 2011.
DOI : 10.1017/S1461145711000885

R. Weisler, M. Joyce, L. Mcgill, L. A. Szamosi, J. Eriksson et al., Abstract, CNS Spectrums, vol.10, issue.06, pp.299-313, 2009.
DOI : 10.1016/j.euroneuro.2007.07.005

B. Bortnick, N. El-khalili, M. Banov, D. Adson, C. Datto et al., Efficacy and tolerability of extended release quetiapine fumarate (quetiapine XR) monotherapy in major depressive disorder: A placebo-controlled, randomized study???, Journal of Affective Disorders, vol.128, issue.1-2, pp.83-94, 2011.
DOI : 10.1016/j.jad.2010.06.031

. Randomized, double-blind study of the efficacy and tolerability of extended release quetiapine fumarate (quetiapine XR) monotherapy in elderly patients with major depressive disorder, Am J Geriatr Psychiatry Off J Am Assoc Geriatr Psychiatry, 2013.

A. Cutler, S. Montgomery, D. Feifel, L. A. Aström, M. Brecher et al., Extended Release Quetiapine Fumarate Monotherapy in Major Depressive Disorder, The Journal of Clinical Psychiatry, vol.70, issue.4, pp.526-565, 2009.
DOI : 10.4088/JCP.08m04592

N. Maneeton, B. Maneeton, M. Srisurapanont, and S. Martin, Quetiapine monotherapy in acute phase for major depressive disorder: a meta-analysis of randomized, placebo-controlled trials, BMC Psychiatry, vol.23, issue.6, p.160, 2012.
DOI : 10.1097/YIC.0b013e328306a987

K. Komossa, A. Depping, A. Gaudchau, W. Kissling, and S. Leucht, Second-generation antipsychotics for major depressive disorder and dysthymia, Cochrane Database Syst Rev, vol.38, issue.5, p.8121, 2010.
DOI : 10.1002/14651858.CD008121.pub2

J. Holtzmann, R. Richieri, G. Saba, N. Allaïli, R. Bation et al., How to define treatment-resistant depression?]. Presse Médicale Paris Fr 1983, pp.354-363, 2016.

M. Bauer, H. Pretorius, E. Constant, W. Earley, J. Szamosi et al., Extended-Release Quetiapine as Adjunct to an Antidepressant in Patients With Major Depressive Disorder, The Journal of Clinical Psychiatry, vol.70, issue.4, pp.540-549, 2009.
DOI : 10.4088/JCP.08m04629

N. El-khalili, M. Joyce, S. Atkinson, R. Buynak, C. Datto et al., Extendedrelease quetiapine fumarate (quetiapine XR) as adjunctive therapy in major depressive disorder (MDD) in patients with an inadequate response to ongoing antidepressant treatment: a multicentre, randomized, double-blind, placebo-controlled study, Int J Neuropsychopharmacol Off Sci J Coll Int Neuropsychopharmacol CINP, 2010.

M. Bauer, R. Mcintyre, J. Szamosi, and H. Eriksson, Evaluation of adjunct extendedrelease quetiapine fumarate on sleep disturbance and quality in patients with major depressive disorder and an inadequate response to on-going antidepressant therapy, Int J Neuropsychopharmacol Off Sci J Coll Int Neuropsychopharmacol CINP, 2013.

A. Mcintyre, A. Gendron, and A. Mcintyre, Quetiapine adjunct to selective serotonin reuptake inhibitors or venlafaxine in patients with major depression, comorbid anxiety, and residual depressive symptoms: a randomized, placebo-controlled pilot study, Depression and Anxiety, vol.8, issue.7
DOI : 10.1002/da.20275

A. Quante, R. F. Schindler, F. Volkmer, K. Severus, E. Urbanek et al., Quetiapine as combination treatment with citalopram in unipolar depression with prominent somatic symptoms: a randomised, double-blind, placebo-controlled pilot study

J. Nelson and G. Papakostas, Atypical Antipsychotic Augmentation in Major Depressive Disorder: A Meta-Analysis of Placebo-Controlled Randomized Trials, American Journal of Psychiatry, vol.166, issue.9, pp.980-91, 2009.
DOI : 10.1176/appi.ajp.2009.09030312

X. Wen, L. Wang, Z. Liu, A. Huang, Y. Liu et al., Meta-analysis on the efficacy and tolerability of the augmentation of antidepressants with atypical antipsychotics in patients with major depressive disorder, Brazilian Journal of Medical and Biological Research, vol.47, issue.7, pp.605-621, 2014.
DOI : 10.1590/1414-431X20143672

J. Dorée, D. Rosiers, J. Lew, V. Gendron, A. Elie et al., Quetiapine augmentation of treatment-resistant depression: a comparison with lithium, Current Medical Research and Opinion, vol.23, issue.2, pp.333-374, 2007.
DOI : 10.1185/030079906X162809

X. Zhou, A. Ravindran, B. Qin, D. Giovane, C. Li et al., Comparative Efficacy, Acceptability, and Tolerability of Augmentation Agents in Treatment-Resistant Depression, The Journal of Clinical Psychiatry, 2015.
DOI : 10.4088/JCP.14r09204

M. Bauer, L. Dell-'osso, S. Kasper, W. Pitchot, D. Vansvik et al., Extended-release quetiapine fumarate (quetiapine XR) monotherapy and quetiapine XR or lithium as add-on to antidepressants in patients with treatment-resistant major depressive disorder, Journal of Affective Disorders, vol.151, issue.1, pp.209-228, 2013.
DOI : 10.1016/j.jad.2013.05.079

P. Turner, R. Kantaria, and A. Young, A systematic review and meta-analysis of the evidence base for add-on treatment for patients with major depressive disorder who have not responded to antidepressant treatment: A European perspective, Journal of Psychopharmacology, vol.162, issue.2, pp.85-98, 2014.
DOI : 10.1016/j.euroneuro.2011.07.018

M. Liebowitz, R. Lam, U. Lepola, C. Datto, D. Sweitzer et al., Efficacy and tolerability of extended release quetiapine fumarate monotherapy as maintenance treatment of major depressive disorder: a randomized, placebo-controlled trial, Depression and Anxiety, vol.193, issue.10, pp.964-76, 2010.
DOI : 10.1002/da.20740

O. Doumy, D. Bennabi, W. El-hage, N. Allaïli, R. Bation et al., Potentiation strategies]. Presse Médicale Paris Fr 1983, pp.333-377, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01482633

D. Carvalho, W. Nuss, P. Blin, P. Arnaud, R. Filipovics et al., Who are patients suffering from bipolar disorders in France? The TEMPPO survey: patients' sociodemographic and clinical characteristics data]. L'Encéphale, pp.211-234, 2012.
URL : https://hal.archives-ouvertes.fr/hal-00712619

P. Nuss, W. De-carvalho, P. Blin, R. Arnaud, A. Filipovics et al., Treatment practices in the management of patients with bipolar disorder in France. The TEMPPO study]. L'Encéphale, Feb, vol.38, issue.1, pp.75-85, 2012.
URL : https://hal.archives-ouvertes.fr/hal-00689013

F. Bellivier, M. Delavest, S. Coulomb, M. Figueira, J. Langosch et al., Therapeutic management of bipolar disorder in France and Europe: a multinational longitudinal study (WAVE-bd)]. L'Encéphale, pp.392-400, 2014.

L. Marston, I. Nazareth, I. Petersen, K. Walters, and D. Osborn, Prescribing of antipsychotics in UK primary care: a cohort study, BMJ Open, vol.71, issue.12, p.6135, 2014.
DOI : 10.1136/bmjopen-2014-006135

L. Judd, H. Akiskal, P. Schettler, W. Coryell, J. Maser et al., The comparative clinical phenotype and long term longitudinal episode course of bipolar I and II: a clinical spectrum or distinct disorders?, Journal of Affective Disorders, vol.73, issue.1-2, pp.19-32, 2003.
DOI : 10.1016/S0165-0327(02)00324-5

C. Baldassano, L. Marangell, L. Gyulai, S. Ghaemi, H. Joffe et al., Gender differences in bipolar disorder: retrospective data from the first 500 STEP-BD participants, Bipolar Disorders, vol.100, issue.1, pp.465-70, 2005.
DOI : 10.1097/01.PSY.0000073871.67679.D8

Á. Frías, I. Baltasar, and B. Birmaher, Comorbidity between bipolar disorder and borderline personality disorder: Prevalence, explanatory theories, and clinical impact, Journal of Affective Disorders, vol.202, pp.210-219, 2016.
DOI : 10.1016/j.jad.2016.05.048

G. Hunt, G. Malhi, M. Cleary, H. Lai, and T. Sitharthan, Prevalence of comorbid bipolar and substance use disorders in clinical settings, 1990???2015: Systematic review and meta-analysis, Journal of Affective Disorders, vol.206, 2009.
DOI : 10.1016/j.jad.2016.07.011

F. Schürhoff, F. Bellivier, R. Jouvent, M. Mouren-siméoni, M. Bouvard et al., Early and late onset bipolar disorders: two different forms of manic-depressive illness?, Journal of Affective Disorders, vol.58, issue.3, pp.215-236, 2000.
DOI : 10.1016/S0165-0327(99)00111-1